Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12064029 | 0.87 | SMN1; SMN2 (0.45) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL12064041 | 0.87 | SMN1; SMN2 (0.45) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL12064309 | 0.87 | SMN1; SMN2 (0.45) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL22207711 | 0.85 | L3MBTL1 (0.49) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL22222570 | 0.85 | L3MBTL1 (0.49) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL28908151 | 0.84 | TAS1R3 (0.35) | SMN1; SMN2ALDH1A1TAS1R3TAS1R1GAA | |
| SCHEMBL28908150 | 0.84 | TAS1R3 (0.35) | SMN1; SMN2ALDH1A1TAS1R3TAS1R1GAA | |
| SCHEMBL24866254 | 0.83 | SMN1; SMN2 (0.42) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL17378386 | 0.83 | GNPAT (0.42) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL4028312 | 0.83 | SMN1; SMN2 (0.42) | KDM4EMAPTTHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3909961-B1 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | CJ CHEILJEDANG CORP (KR) | 2026-02-18 | — | — | EP | disclosed |
| US-12534482-B2 | Method of producing L-glufosinate | CJ CHEILJEDANG CORPORATION (KR) | 2026-01-27 | — | — | US | disclosed |
| EP-3909962-B1 | METHOD OF PRODUCING L-GLUFOSINATE | CJ CHEILJEDANG CORP (KR) | 2025-05-21 | — | — | EP | disclosed |
| US-12252502-B2 | L-glufosinate intermediate and L-glufosinate preparation method | CJ CHEILJEDANG CORPORATION (KR) | 2025-03-18 | — | — | US | disclosed |
| CN-113316580-B | Preparation method of L-glufosinate | CJ第一制糖株式会社 | 2024-11-19 | — | — | CN | disclosed |
| US-20220306658-A1 | METHOD OF PRODUCING L-GLUFOSINATE | CJ CHEILJEDANG CORPORATION (KR) | 2022-09-29 | — | — | US | disclosed |
| US-20220024955-A1 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | CJ CHEILJEDANG CORPORATION (KR) | 2022-01-27 | — | — | US | disclosed |
| EP-3909962-A1 | METHOD OF PRODUCING L-GLUFOSINATE | CJ Cheiljedang Corporation (KR) | 2021-11-17 | — | — | EP | disclosed |
| EP-3909961-A1 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | CJ Cheiljedang Corporation (KR) | 2021-11-17 | — | — | EP | disclosed |
| CN-113316581-A | L-glufosinate-ammonium intermediate and preparation method of L-glufosinate-ammonium | CJ第一制糖株式会社 | 2021-08-27 | — | — | CN | disclosed |
| CN-113316580-A | Preparation method of L-glufosinate-ammonium | CJ第一制糖株式会社 | 2021-08-27 | — | — | CN | disclosed |
| WO-2020145513-A1 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | 씨제이제일제당(주) | 2020-07-16 | — | — | WO | disclosed |
| WO-2020145514-A1 | METHOD OF PRODUCING L-GLUFOSINATE | 씨제이제일제당(주) | 2020-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12252502-B2 | L-glufosinate intermediate and L-glufosinate preparation method | GLUL, ASNS, PGLS | KDM4E 4500/4885MAPT 3863/4885THRB 3949/4885 |
| US-12534482-B2 | Method of producing L-glufosinate | GLUL, ASNS, GLRB | KDM4E 4340/4885MAPT 4385/4885THRB 689/4885 |
| US-20220306658-A1 | METHOD OF PRODUCING L-GLUFOSINATE | GLUL, ASNS, PGLS | KDM4E 4261/4885MAPT 2973/4885THRB 2777/4885 |
| US-20220024955-A1 | L-GLUFOSINATE INTERMEDIATE AND L-GLUFOSINATE PREPARATION METHOD | GLUL, ASNS, PGLS | KDM4E 4500/4885MAPT 3863/4885THRB 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.